Clinical trials for a possible treatment of coronavirus, an antiviral drug called Remdesivir, have begun. Over 750 patients have been enrolled in the trials, which will be conducted in several hospitals in Wuhan.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3